Share this article on:

TOUCH® Patient Reported Outcomes Study: The Impact of Natalizumab on Common Measures of Quality of Life in CD patients: P‐64

Kane, Sunanda1; Nag, Arpita2; Taylor, Lori3; Hogge, Gary4; Colombel, Jean‐Frédéric5; Lewis, James6; Rubin, David7; Panaccione, Remo8

Abstracts from the 2012 Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's National Clinical & Research Conference December 13-15, 2012 Hollywood, Florida: Clinical Poster Presentations